|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 2.02 EUR | +1.25% |
|
-1.46% | +7.16% |
| Apr. 15 | Faron Pharmaceuticals reappoints former finance chief on interim basis | AN |
| Feb. 14 | Biohit Oyj Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
Biohit Oyj reported earnings results for the full year ended December 31, 2023. For the full year, the company reported sales was EUR 13.1 million compared to EUR 11 million a year ago. Net income was EUR 1.9 million compared to EUR 0.6 million a year ago.
Basic earnings per share from continuing operations was EUR 0.12 compared to EUR 0.04 a year ago. Diluted earnings per share from continuing operations was EUR 0.12 compared to EUR 0.04 a year ago.
| 1st Jan change | Capi. | |
|---|---|---|
| +7.16% | 32.72M | |
| +7.13% | 7.91B | |
| -3.15% | 4.66B | |
| -9.18% | 2.84B | |
| +1.11% | 2.03B | |
| -26.56% | 1.12B | |
| -22.71% | 759M | |
| -13.49% | 755M | |
| -56.85% | 682M | |
| -24.66% | 671M |
BIOHIT OYJ 
